Changes in Pediatric Tetracycline Prescribing Patterns During the 2024 Mycoplasma pneumoniae Pneumonia Epidemic in the Republic of Korea.
BACKGROUND Although macrolide-resistant Mycoplasma pneumoniae pneumonia prevalence exceeds 90% in the Republic of Korea, health insurance reimbursement policies historically restrict guideline-recommended tetracycline use in children aged <12 years. After a post-pandemic outbreak, reimbursement coverage was expanded in...